BCG Vaccination to Prevent COVID-19

Summary

BCG Vaccination to Prevent COVID-19 is a clinical trial^[1].

Key Facts

• BCG Vaccination to Prevent COVID-19 is in the country of United States^[2].
• BCG Vaccination to Prevent COVID-19's instance of is recorded as clinical trial^[3].
• BCG Vaccination to Prevent COVID-19's start time is recorded as +2020-11-30T00:00:00Z^[4].
• BCG Vaccination to Prevent COVID-19's end time is recorded as +2022-11-30T00:00:00Z^[5].
• BCG Vaccination to Prevent COVID-19's sponsor is recorded as Henry M. Jackson Foundation for the Advancement of Military Medicine^[6].
• BCG Vaccination to Prevent COVID-19's main subject is recorded as clinical trial^[7].
• BCG Vaccination to Prevent COVID-19's number of participants is recorded as {'unit': '1', 'amount': '+550'}^[8].
• BCG Vaccination to Prevent COVID-19's title is recorded as Novel Use of an Existing Vaccine (BCG) Alliance: The NUEVA Trial^[9].
• BCG Vaccination to Prevent COVID-19's short name is recorded as NUEVA^[10].
• BCG Vaccination to Prevent COVID-19's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• BCG Vaccination to Prevent COVID-19's ClinicalTrials.gov ID is recorded as NCT04632537^[12].
• BCG Vaccination to Prevent COVID-19's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+64'}^[13].
• BCG Vaccination to Prevent COVID-19's research intervention is recorded as BCG vaccine^[14].
• BCG Vaccination to Prevent COVID-19's clinical trial phase is recorded as phase III clinical trial^[15].
• BCG Vaccination to Prevent COVID-19's research subject recruitment status is recorded as not yet recruiting^[16].
• BCG Vaccination to Prevent COVID-19's study type is recorded as interventional study^[17].